Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114 Million
— Extension led by Pfizer with participation from new investors Walleye Capital and Asabys Partners as well as existing investors — — Funding will support next stage of clinical and corporate development — GHENT, Belgium–(BUSINESS WIRE)–Agomab Therapeutics NV (‘Agomab’) today announced it has extended its Series B financing round with an additional close of $40.5 … [Read more…]
